Insider · CIK 0001190644

INGRAM DOUGLAS S

Reports to the SEC for 8 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001190644

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-09	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+32.9K sh	—	—	32,947
2025-12-16	ARWRARROWHEAD PHARMACEUTICALS, INC.A Award	Director	AAward	+7,819 sh	—	—	46,215
2025-12-07	SRPTSarepta Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+270K sh	—	—	929,391
2025-12-07	SRPTSarepta Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+50K sh	—	—	440,307
2025-12-07	SRPTSarepta Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+96.5K sh	—	—	659,849
2025-12-07	SRPTSarepta Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+73K sh	—	—	563,308
2025-12-07	SRPTSarepta Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+50K sh	—	—	490,307
2025-06-06	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+137K sh	—	—	136,681
2025-02-06	ARWRARROWHEAD PHARMACEUTICALS, INC.A Award	Director	AAward	+38.4K sh	$20.09	+$771K	38,396
2024-06-03	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+102K sh	—	—	102,225
2023-11-03	SRPTSarepta Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+11.1K sh	$79.70	+$881K	386,223
2023-11-03	SRPTSarepta Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+200 sh	$81.26	+$16.3K	390,307
2023-11-03	SRPTSarepta Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+3,884 sh	$80.33	+$312K	390,107
2023-11-03	SRPTSarepta Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+10.1K sh	$78.57	+$792K	375,163
2023-05-31	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+66.1K sh	—	—	66,055
2022-05-27	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+41.6K sh	—	—	41,597
2021-11-17	SRPTSarepta Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+25K sh	$79.94	+$2M	365,082
2021-06-26	SRPTSarepta Therapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−17.8K sh	$80.40	−$1.43M	340,056
2021-05-19	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16K sh	—	—	16,000
2020-12-31	SRPTSarepta Therapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−37.1K sh	$170.49	−$6.33M	357,868
2020-07-20	RLAYRelay Therapeutics, Inc.P Purchase	Director	PPurchase	+25K sh	$20.00	+$500K	25,000
2019-12-31	SRPTSarepta Therapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−37.2K sh	$129.04	−$4.8M	395,012
2019-08-12	SRPTSarepta Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+8,460 sh	$122.76	+$1.04M	424,405
2019-08-12	SRPTSarepta Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+7,792 sh	$123.41	+$962K	432,197
2018-10-30	SRPTSarepta Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+3,134 sh	$120.94	+$379K	415,945
2018-10-30	SRPTSarepta Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+13.6K sh	$120.26	+$1.63M	412,811
2018-08-15	SRPTSarepta Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+16K sh	$125.26	+$2M	399,250
2018-06-26	SRPTSarepta Therapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−36.9K sh	$135.53	−$5.01M	383,250
2017-11-08	SRPTSarepta Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+38.1K sh	$52.44	+$2M	420,196
2017-07-27	SRPTSarepta Therapeutics, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+47.1K sh	$42.50	+$2M	382,058
2017-06-26	SRPTSarepta Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+3.3M sh	—	—	3,300,000
2017-06-26	SRPTSarepta Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+335K sh	—	—	335,000
2017-06-09	Endo International plcA Award	Director	AAward	+23.9K sh	—	—	28,824
2017-06-09	Endo International plcF Tax Payment	Director	FTax Payment	−11.5K sh	$11.49	−$132K	17,336
2016-05-05	Endo International plcA Award	Director	AAward	+9,403 sh	$26.59	+$250K	9,403
2016-05-05	Endo International plcS Sale	Director	SSale	−4,513 sh	$26.59	−$120K	4,890
2016-05-05	Endo International plcA Award	Director	AAward	+9,403 sh	$26.59	+$250K	9,403
2015-10-20	SKYESkye Bioscience, Inc.A Award	Director, Vice Chairman	AAward	+60K sh	—	—	372,500
2015-08-20	SKYESkye Bioscience, Inc. · Series A Preferred StockC Conversion	Director, Vice Chairman	CConversion	−100K sh	—	—	0
2015-08-20	SKYESkye Bioscience, Inc.C Conversion	Director, Vice Chairman	CConversion	+313K sh	—	—	312,500
2015-06-01	SKYESkye Bioscience, Inc. · Stock Option (Right to Buy)A Award	Director, Vice Chairman	AAward	+40K sh	—	—	40,000
2015-03-17	ALLERGAN INCD Disposition to Issuer	President	DDisposition to Issuer	−3,616.499 sh	—	—	0
2015-03-17	ALLERGAN INCD Disposition to Issuer	President	DDisposition to Issuer	−2,676.788 sh	—	—	0
2015-03-17	ALLERGAN INCD Disposition to Issuer	President	DDisposition to Issuer	−10.8K sh	—	—	0
2015-03-17	ALLERGAN INCD Disposition to Issuer	President	DDisposition to Issuer	−16.9K sh	—	—	0
2015-03-17	ALLERGAN INCA Award	President	AAward	+16.9K sh	—	—	16,911.004
2015-03-17	ALLERGAN INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	President	DDisposition to Issuer	−106K sh	—	—	0
2015-03-17	ALLERGAN INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	President	DDisposition to Issuer	−67K sh	—	—	0
2015-03-17	ALLERGAN INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	President	DDisposition to Issuer	−89.2K sh	—	—	0
2015-03-17	ALLERGAN INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	President	DDisposition to Issuer	−92.6K sh	—	—	0

Recent filings

Accepted (ET)
Jun 104
INGRAM DOUGLAS S0001193125-26-265905
SEC(opens sec.gov)
Dec 184
INGRAM DOUGLAS S0001190644-25-000004
SEC(opens sec.gov)
Dec 94
INGRAM DOUGLAS S0001193125-25-313184
SEC(opens sec.gov)
Jun 64
INGRAM DOUGLAS S0000950170-25-083311
SEC(opens sec.gov)
Feb 74
INGRAM DOUGLAS S0001628280-25-004478
SEC(opens sec.gov)
Jun 54
INGRAM DOUGLAS S0000950170-24-069556
SEC(opens sec.gov)
Nov 64
INGRAM DOUGLAS S0001209191-23-054441
SEC(opens sec.gov)
Jun 14
INGRAM DOUGLAS S0001209191-23-033442
SEC(opens sec.gov)
May 274
INGRAM DOUGLAS S0001209191-22-032682
SEC(opens sec.gov)
Nov 174
INGRAM DOUGLAS S0001209191-21-065246
SEC(opens sec.gov)
Jun 284
INGRAM DOUGLAS S0001209191-21-043582
SEC(opens sec.gov)
May 214
INGRAM DOUGLAS S0001209191-21-035112
SEC(opens sec.gov)
Jan 44
INGRAM DOUGLAS S0001209191-21-000556
SEC(opens sec.gov)

Companies

Address

C/O RELAY THERAPEUTICS, INC. 60 HAMPSHIRE STREET

CAMBRIDGE, MA, 02139